相关实验视频

Updated: Jan 13, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

在帕金森病的两分钟步骤测试的有效性,可靠性和协议

Delso Honório da Silva Junior¹, Hélcio Kanegusuku¹, Verônica de Fátima Souza Lima¹

¹Nove de Julho University, São Paulo, Brazil.

Geriatric nursing (New York, N.Y.)

|October 28, 2025

概括

两分钟步骤测试 (2MST) 是早期 (H&Y 1-2) 帕金森病 (PD) 患者的有效和可靠测量方法. 它在评估轻度至中度PD患者的功能能力方面表现出良好的可靠性和有效性.

科学领域:

神经学神经学
物理疗法物理治疗
老年学是一门学科.

背景情况:

帕金森病 (PD) 显著影响移动性和功能能力.
在PD中评估功能状态需要可靠和有效的测量工具.
两分钟步骤测试 (2MST) 是评估PD患者功能性移动性的潜在工具.

研究的目的:

在不同严重程度的帕金森病 (PD) 患者中评估2MST的有效性和可靠性.
为了将2MST的表现与PD患者的6分钟步行测试 (6MWT) 进行比较.
为了确定2MST的测试-重新测试可靠性,在PD患者中按Hoehn和Yahr (H&Y) 阶段分类.

主要方法:

50名患有PD的参与者根据H&Y阶段分为两组:1-2和3-4.
参与者在"启动"药物状态期间两次执行了2MST和6MWT.
统计分析包括相关性 (r) 和对有效性和可靠性的显著性测试 (P值).

主要成果:

在两个H&Y阶段组中,在6MWT和2MST之间发现了显著的正相关性 (r=0.741在1-2阶段;r=0.519在3-4阶段).
2MST在患有H&Y阶段1-2 (P>0.05) 的PD患者中表现出良好的测试-重试可靠性.
在H&Y阶段3-4的PD患者在第二次测试中显示了2MST表现的显著提高 (P<0.05),表明潜在的学习或疲劳效应.

结论:

2MST表现出良好的可靠性和有效性指标,用于评估早期帕金森病 (H&Y阶段1-2) 患者的功能能力.
由于观察到的测试-重新测试差异,可能需要进一步的研究来完善2MST在更先进的PD阶段 (H&Y 3-4) 的使用.

关键词:

运动测试运动测试功能能力功能能力神经退行性疾病的神经退行性疾病步行走路走路

更多相关视频

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on: November 23, 2019

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults

Clinical Assessment of Spatiotemporal Gait Parameters in Patients and Older Adults

Published on: November 7, 2014

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...